These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 21539538)
41. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Chitturi S; Farrell G; Frost L; Kriketos A; Lin R; Fung C; Liddle C; Samarasinghe D; George J Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049 [TBL] [Abstract][Full Text] [Related]
42. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Van Berendoncks AM; Garnier A; Beckers P; Hoymans VY; Possemiers N; Fortin D; Martinet W; Van Hoof V; Vrints CJ; Ventura-Clapier R; Conraads VM Circ Heart Fail; 2010 Mar; 3(2):185-94. PubMed ID: 20103776 [TBL] [Abstract][Full Text] [Related]
43. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B. Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167 [TBL] [Abstract][Full Text] [Related]
44. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies. Petridou ET; Mitsiades N; Gialamas S; Angelopoulos M; Skalkidou A; Dessypris N; Hsi A; Lazaris N; Polyzos A; Syrigos C; Brennan AM; Tseleni-Balafouta S; Mantzoros CS Oncology; 2007; 73(3-4):261-9. PubMed ID: 18424891 [TBL] [Abstract][Full Text] [Related]
45. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344 [TBL] [Abstract][Full Text] [Related]
46. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients. Yoneda M; Saito S; Ikeda T; Fujita K; Mawatari H; Kirikoshi H; Inamori M; Nozaki Y; Akiyama T; Takahashi H; Abe Y; Kubota K; Iwasaki T; Terauchi Y; Togo S; Nakajima A J Viral Hepat; 2007 Sep; 14(9):600-7. PubMed ID: 17697011 [TBL] [Abstract][Full Text] [Related]
47. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection. Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519 [TBL] [Abstract][Full Text] [Related]
48. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association. Knobler H; Zhornicky T; Sandler A; Haran N; Ashur Y; Schattner A Am J Gastroenterol; 2003 Dec; 98(12):2751-6. PubMed ID: 14687828 [TBL] [Abstract][Full Text] [Related]
49. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C. Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344 [TBL] [Abstract][Full Text] [Related]
50. Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan. Hsieh MH; Lee LP; Hsieh MY; Tsai KB; Huang JF; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Dai CY; Chuang WL; Yu ML Jpn J Infect Dis; 2007 Nov; 60(6):377-81. PubMed ID: 18032828 [TBL] [Abstract][Full Text] [Related]
51. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Inoue M; Maehata E; Yano M; Taniyama M; Suzuki S Metabolism; 2005 Mar; 54(3):281-6. PubMed ID: 15736103 [TBL] [Abstract][Full Text] [Related]
52. Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. Hui CK; Zhang HY; Lee NP; Chan W; Yueng YH; Leung KW; Lu L; Leung N; Lo CM; Fan ST; Luk JM; Xu A; Lam KS; Kwong YL; Lau GK; J Hepatol; 2007 Aug; 47(2):191-202. PubMed ID: 17462782 [TBL] [Abstract][Full Text] [Related]
53. Contribution of obesity to hepatitis C-related fibrosis progression. Ortiz V; Berenguer M; Rayón JM; Carrasco D; Berenguer J Am J Gastroenterol; 2002 Sep; 97(9):2408-14. PubMed ID: 12358265 [TBL] [Abstract][Full Text] [Related]
54. Comparative study between occult hepatitis C virus infection and chronic hepatitis C. Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Castillo I; Carreño V J Viral Hepat; 2007 Jan; 14(1):36-40. PubMed ID: 17212642 [TBL] [Abstract][Full Text] [Related]
55. [Adiponectin and chronic viral hepatitis]. Yin HZ; Cao ZC Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):955-7. PubMed ID: 20038346 [No Abstract] [Full Text] [Related]
56. Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis. Nkontchou G; Bastard JP; Ziol M; Aout M; Cosson E; Ganne-Carrie N; Grando-Lemaire V; Roulot D; Capeau J; Trinchet JC; Vicaut E; Beaugrand M J Hepatol; 2010 Nov; 53(5):827-33. PubMed ID: 20728234 [TBL] [Abstract][Full Text] [Related]
57. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473 [TBL] [Abstract][Full Text] [Related]
58. Selenium deficiency is associated with insulin resistance in patients with hepatitis C virus-related chronic liver disease. Himoto T; Yoneyama H; Kurokohchi K; Inukai M; Masugata H; Goda F; Haba R; Watababe S; Kubota S; Senda S; Masaki T Nutr Res; 2011 Nov; 31(11):829-35. PubMed ID: 22118753 [TBL] [Abstract][Full Text] [Related]
59. Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection. Kara B; Gunesacar R; Doran F; Kara IO; Akkiz H Adv Ther; 2007; 24(5):972-82. PubMed ID: 18029322 [TBL] [Abstract][Full Text] [Related]
60. Are decreased AdipoR1 mRNA levels associated with adiponectin resistance in coronary artery disease patients? Sopić M; Joksić J; Spasojević-Kalimanovska V; Kalimanovska-Oštrić D; Anđelković K; Jelić-Ivanović Z Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):331-6. PubMed ID: 25582653 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]